125 related articles for article (PubMed ID: 37688931)
1. Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe.
Guthmuller S; Carrieri V; Wübker A
J Health Econ; 2023 Dec; 92():102803. PubMed ID: 37688931
[TBL] [Abstract][Full Text] [Related]
2. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
Zakaria D; Shaw A
Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
[TBL] [Abstract][Full Text] [Related]
3. Barriers to Organized Mammography Screening Programs in Hungary: A Questionnaire-based Study of 3,313 Women.
Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Bak M; Kásler M; Kovács T; Mátrai Z
Anticancer Res; 2018 Mar; 38(3):1727-1734. PubMed ID: 29491109
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.
Njor S; Nyström L; Moss S; Paci E; Broeders M; Segnan N; Lynge E;
J Med Screen; 2012; 19 Suppl 1():33-41. PubMed ID: 22972809
[TBL] [Abstract][Full Text] [Related]
5. Effect of organized mammography screening on breast cancer mortality: A population-based cohort study in Norway.
Møller MH; Lousdal ML; Kristiansen IS; Støvring H
Int J Cancer; 2019 Feb; 144(4):697-706. PubMed ID: 30144028
[TBL] [Abstract][Full Text] [Related]
6. Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries.
Iwamoto Y; Kaucher S; Lorenz E; Bärnighausen T; Winkler V
BMC Public Health; 2019 Jun; 19(1):823. PubMed ID: 31242882
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer screening programmes and self-reported mammography use in European countries.
Cardoso R; Hoffmeister M; Brenner H
Int J Cancer; 2023 Jun; 152(12):2512-2527. PubMed ID: 36883419
[TBL] [Abstract][Full Text] [Related]
8. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
Katalinic A; Eisemann N; Kraywinkel K; Noftz MR; Hübner J
Int J Cancer; 2020 Aug; 147(3):709-718. PubMed ID: 31675126
[TBL] [Abstract][Full Text] [Related]
10. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
Kalager M; Adami HO; Bretthauer M; Tamimi RM
Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
[TBL] [Abstract][Full Text] [Related]
11. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.
Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chen SL; Chiu SY; Fann JC; Ku MM; Wu WY; Hsu CY; Chen YC; Svane G; Azavedo E; Grundström H; Sundén P; Leifland K; Frodis E; Ramos J; Epstein B; Åkerlund A; Sundbom A; Bordás P; Wallin H; Starck L; Björkgren A; Carlson S; Fredriksson I; Ahlgren J; Öhman D; Holmberg L; Chen TH
Cancer; 2020 Jul; 126(13):2971-2979. PubMed ID: 32390151
[TBL] [Abstract][Full Text] [Related]
12. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
Tabár L; Dean PB; Chen TH; Yen AM; Chen SL; Fann JC; Chiu SY; Ku MM; Wu WY; Hsu CY; Chen YC; Beckmann K; Smith RA; Duffy SW
Cancer; 2019 Feb; 125(4):515-523. PubMed ID: 30411328
[TBL] [Abstract][Full Text] [Related]
13. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
[TBL] [Abstract][Full Text] [Related]
14. The effect of organized breast cancer screening on mammography use: Evidence from France.
Buchmueller TC; Goldzahl L
Health Econ; 2018 Dec; 27(12):1963-1980. PubMed ID: 30084221
[TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
16. Pan-Canadian study of mammography screening and mortality from breast cancer.
Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
[TBL] [Abstract][Full Text] [Related]
17. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
18. International programs for the detection of breast cancer.
Smith RA
Salud Publica Mex; 2011; 53(5):394-404. PubMed ID: 22218793
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark.
Lynge E; Beau AB; von Euler-Chelpin M; Napolitano G; Njor S; Olsen AH; Schwartz W; Vejborg I
Breast Cancer Res Treat; 2020 Dec; 184(3):891-899. PubMed ID: 32862304
[TBL] [Abstract][Full Text] [Related]
20. [Evaluating the benefits of mammographic breast cancer screening].
Kullmann T; Misset JL
Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
